DXR US2394671034

Rapport

Vertraagde tijd Nyse - 20:50 08-08-2022
13.90	USD		+1.02%

21/07	Daxor Corporation kondigt partnerschap met Medaxiom aan	CI
27/06	Daxor en de Uniformed Services University gaan samenwerken aan een nieuw apparaat voor de analyse van het bloedvolume	MT
27/06	Daxor Corporation kondigt fase II-overeenkomst voor coöperatief onderzoek en ontwikkeling aan met de Uniformed Armed Services University voor de ontwikkeling van een niet-nucleair bloedvolume-analyseapparaat (Bva)	CI

Nieuws

Persberichten

Officiële publicaties

Sectornieuws

Communiqués de presse de la société DAXOR CORPORATION

27/07	Daxor Corporation Announces a 49.4% Increase In Its Single-Use Diagnostic Kits Year-Ove..	GL
27/07	Daxor Corporation Announces a 49.4% Increase In Its Single-Use Diagnostic Kits Year-Ove..	AQ
21/07	Daxor corporation announces partnership with medaxiom to advance awareness and further ..	GL
21/07	Daxor corporation announces partnership with medaxiom to advance awareness and further ..	AQ
18/07	Daxor completes nih funded i-corps program for commercialization of clinical decision s..	GL
18/07	Daxor completes nih funded i-corps program for commercialization of clinical decision s..	AQ
29/06	DAXOR CORP : Submission of Matters to a Vote of Security Holders (form 8-K)	AQ
27/06	Daxor announces cooperative research and development phase ii agreement with the unifor..	GL
27/06	Daxor announces cooperative research and development phase ii agreement with the unifor..	AQ
13/06	Daxor Corporation to Showcase the Benefits of BVA-100® Guided-Care at the American Asso..	GL
13/06	Daxor Corporation to Showcase the Benefits of BVA-100® Guided-Care at the American Asso..	AQ
25/05	Daxor's Blood Volume Analyzer (BVA-100®) To Be Used As a Key Metric in Study of “..	GL
25/05	Daxor's Blood Volume Analyzer (BVA-100®) To Be Used As a Key Metric in Study of “..	AQ
12/05	Daxor Corporation to Present at the H.C. Wainwright & Company Global Investment Confere..	GL
12/05	Daxor Corporation to Present at the H.C. Wainwright & Company Global Investment Confere..	GL
02/05	New Data Validates Blood Volume Analysis Guided-Care, Improves Survival in Patients wit..	GL
02/05	New Data Validates Blood Volume Analysis Guided-Care, Improves Survival in Patients wit..	AQ
06/04	New Study from Duke Heart Demonstrates the Unique Accuracy and Utility of Daxor's Blood..	AQ
23/03	Daxor Corporation to Participate in the Maxim Group 2022 Virtual Growth Conference	AQ
01/03	Daxor Corporation CEO and President Michael Feldschuh Provides Corporate Update in Lett..	AQ
01/03	Daxor Corporation Announces $1.35 Per Share NAV Increase and Files Annual Report for Fi..	AQ
17/02	Study Demonstrates Importance and Clinical Utility of Daxor's Blood Volume (BVA-100®) D..	AQ
02/02	DAXOR : Commences Trading on The NASDAQ Capital Market - Form 8-K	PU
02/02	DAXOR CORP : Other Events (form 8-K)	AQ
02/02	Daxor Corporation Commences Trading on The NASDAQ Capital Market	AQ
24/01	DAXOR CORP : Change in Directors or Principal Officers (form 8-K)	AQ
21/01	Caleb DesRosiers, JD, MPA Appointed to Daxor Corporation Board of Directors	GL
20/01	DAXOR : to Commence Trading on The Nasdaq Capital Market On February 2, 2022 - Form 8-K	PU
20/01	DAXOR CORP : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standar..	AQ
20/01	Daxor Corporation to Commence Trading on The Nasdaq Capital Market On February 2, 2022	AQ
06/01	Daxor Corporation to Present at the H.C. Wainwright BioConnect 2022 Virtual Conference	AQ
05/01	Daxor announces key milestones achieved for multicenter bva-100® study in hospitalized ..	AQ
04/01	Daxor awarded new patent for blood volume guidance technology to improve treatment and ..	AQ
2021	Daxor Corporation Presents New Data Validating the Benefit of the BVA-100® Blood Test f..	AQ
2021	New Research Demonstrates Clinical Utility of Daxor Corporation Blood Volume (BVA-100®)..	AQ
2021	DAXOR CORPORATION : Receives $200K Matching Fund Award from Launch Tennessee	AQ
2021	Daxor Corporation Presents New Data Validating the Benefit of the BVA-100® Blood Test f..	GL
2021	DAXOR CORPORATION : To Present Compelling New Data and Clinical Trials Utilizing the BVA-1..	AQ
2021	DAXOR CORPORATION : to Present at the H.C. Wainwright 23rd Annual Global Investment Virtua..	AQ
2021	DAXOR CORPORATION : CEO and President Michael Feldschuh Provides Corporate Update in Lette..	AQ
2021	DAXOR CORPORATION : Reports a 26.5 Percent Rise in Diagnostic Sales Revenue in Form N-CSR ..	AQ
2021	DAXOR : Blood Volume (BVA-100®) Diagnostic Demonstrates Clinical Utility In Critically-Ill..	AQ
2021	DAXOR : Announces non-government distribution agreement with concordance® healthcare solut..	AQ
2021	DAXOR : American College of Cardiology (ACC) Features Expert Analysis on the Importance of..	AQ
2021	DAXOR CORP : Submission of Matters to a Vote of Security Holders (form 8-K)	AQ
2021	DAXOR : to Present at the Summer Solstice – Best Ideas from the Buy Side Conference ..	PU
2021	Daxor Corporation to Present at the Summer Solstice - Best Ideas from the Buy Side Conf..	GL
2021	DAXOR CORPORATION : Announces 61% Increase in Q1 2021 Sales Revenue and Further Acquisitio..	AQ
2021	DAXOR CORP : Other Events (form 8-K)	AQ
2021	DAXOR CORPORATION : Receives National Institutes of Health (NIH) Funding Notification for ..	AQ
2021	DAXOR : Newly Published Study Demonstrates Clinical Utility of Daxor's Blood Volume (BVA-1..	AQ
2021	Daxor corporation to participate in benzinga biotech small cap conference	GL
2021	Daxor to Participate in the Maxim Group 2021 Emerging Growth Virtual Conference	GL
2021	DAXOR CORP : Other Events (form 8-K)	AQ
2021	Daxor corporation announces novel fluorescent tracer and phase-two us air force contrac..	GL
2021	Daxor to Present at the H.C. Wainwright Global Life Sciences Conference	GL
2021	Daxor Corporation Announces $0.48 Per Share NAV Increase and Files Annual Report for Fi..	GL
2021	Daxor corporation receives iso 13485 quality management system certification for the bl..	GL
2021	Daxor corporation awarded grant from the center for advancing point of care technologie..	GL
2021	New Research Demonstrates the Clinical Utility with Daxor's Blood Volume Analyzer (BVA-..	GL
2021	DAXOR : To exhibit at the society for critical care medicine 50th congress virtual event	AQ
2021	DAXOR : Announces new distribution agreement with l1 enterprises government distributor	AQ
2021	Daxor to Present at the Inaugural H.C. Wainwright BioConnect 2021 Conference	GL
2020	Daxor Corporation Announces Further Acquisitions of its BVA-100® Blood Volume Analyzer ..	GL
2020	DAXOR CORPORATION : to Present at the 13th Annual LD Micro Main Event 2020	AQ
2020	DAXOR : Third hospital joins multicenter covid-19 bva-100® blood test study	AQ
2020	Third hospital joins multicenter covid-19 bva-100® blood test study	GL
2020	DAXOR : Oregon health & science university joins multicenter covid-19 bva-100® study	AQ
2020	Oregon health & science university joins multicenter covid-19 bva-100® study	GL
2020	DAXOR : to Present at the 2020 MicroCap Rodeo Best Ideas Bowl	AQ
2020	Daxor to Present at the 2020 MicroCap Rodeo Best Ideas Bowl	GL
2020	DAXOR : New Research Shows Daxor's BVA-100® Blood Test Provides Unique Benefit in Detectin..	AQ
2020	New Research Shows Daxor's BVA-100® Blood Test Provides Unique Benefit in Detecting Ane..	GL
2020	DAXOR CORP : Other Events (form 8-K)	AQ
2020	DAXOR : New Research Demonstrates Daxor BVA-100® Blood Test Provides “Extremely Cost..	AQ

1 2 3 4 Volgende

Komende gebeurtenissen in de sector

17/08/22	SPROTT PHYSICAL GOLD TRUST : Eerste halfjaar 2022 Cijferpublicaties (schatting)
18/08/22	PERSHING SQUARE HOLDINGS, LTD. : Eerste halfjaar 2022 Cijferpublicaties (schatting)
25/10/22	ARES CAPITAL CORPORATION : Q3 2022 Cijferpublicaties (schatting)
10/11/22	FS KKR CAPITAL CORP. : Q3 2022 Cijferpublicaties (schatting)

Meer evenementen

Sector

Financiën
	Collectieve investeringen
		Collectieve investeringen
			Gesloten eindfondsen
				Gesloten eindfondsen